๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chongqing
Clinical trial register · China

Clinical Trials in Chongqing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca99 Merck Sharp & Dohme LLC39 Janssen Research & Development, LLC38 First Affiliated Hospital of Chongqing Medical University37 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University30
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Chongqing

1056 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
NCT07789483Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Beijing, Chongqing, Guangzhou, Guiyang, Harbin, Wuhan, Changsha, Nanjing
2027-11-23
Not yet open
Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD
NCT07698223Diabetic Nephropathy
Chen Xiangmei
Phase 4
410
Beijing, Chongqing, Dalian, Shanghai, Hangzhou
2027-03-01
Not yet open
Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A
NCT06136507Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
76
Chongqing, Guangzhou, Guizhou, Hangzhou, Hefei, Nanjing, Qingdao, Shenzhen
2026-12-25
Not yet open
A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies
NCT07789015Idiopathic Inflammatory Myopathies
Boehringer Ingelheim
Phase 3
270
Beijing, Chongqing, Dongguan, Guangzhou, Hefei, Luoyang, Nanchang, Nanjing
2026-11-09
Not yet open
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
NCT07821606Platinum-sensitive Recurrent Ovarian Cancer
Hansoh BioMedical R&D Company
Phase 3
460
Hefei, Beijing, Chongqing, Xiamen, Guangzhou, Shaoguan, Nanning, Harbin
2026-11-01
Not yet open
Deep Cervical Lymphovenous Anastomosis for Severe Alzheimer's Disease
NCT07669272Alzheimer s Disease
Southwest Hospital, China
Not applicable
59
Chongqing
2026-10-01
Recruiting
Sertraline Combined With Multi-Strain Probiotics for Adolescent Depression
NCT07645157Major Depressive Disorder (MDD), Probiotic Intervention
First Affiliated Hospital of Chongqing Medical University
Phase 2
120
Chongqing
2026-10-01
Not yet open
Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy
NCT07789184Gastric Cancer, Peritoneal Metastasis
Hua Huang, MD, PhD
Phase 3
170
Beijing, Chongqing, Zhangzhou, Guangzhou, Wuhan, Nanjing, Nantong, Nanchang
2026-10-01
Not yet open
A Phase 3 Study to Compare the Efficacy of ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r/r MCL).
NCT07784101Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3
280
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan
2026-10
Not yet open
A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anfluยฎ) Pregnant Women (AnFLU-PREG)
NCT07832201Influenza
Sinovac Biotech Co., Ltd
Phase 4
150
Changsha, Chengdu, Chongqing, Guangzhou, Nanjing, Wuhan
2026-10
Not yet open
Safety and Efficacy Evaluation of Single-Port Versus Multi-Port Robotic-Assisted Radical Distal Gastrectomy for Gastric Cancer
NCT07828899STOMACH NEOPLASM, Robotic Surgical Procedures
First Affiliated Hospital of Wenzhou Medical University
Not applicable
212
Shijiazhuang, Jinan, Wenzhou, Beijing, Chongqing
2026-10
Not yet open
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
NCT07680790Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Phase 3
850
Beijing, Chongqing, Fuzhou, Dongguan Shi, Guangzhou, Jiangmen, Zhongshan, Guilin
2026-09-30
Not yet open
Preoperative Oral Carbohydrate Loading and Gastrointestinal Recovery After Bariatric Surgery in Metabolic Syndrome
NCT07822763Metabolic Syndrome (MetS)
First Affiliated Hospital of Chongqing Medical University
Not applicable
208
Chongqing
2026-09-30
Not yet open
An Open-label Study of SG1827 Combined With Anti-PD-1/PD-L1 Antibody and Bevacizumab in Patients With Advanced Solid Tumors
NCT07774611Advanced Solid Tumors
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1/2
180
Chongqing, Fuzhou, Guanzhou, Chengde, Haerbin, Xinxiang, Changsha, Changchun
2026-09-22
Not yet open
Renal Oxygenation-Guided AKI Reduction Trial
NCT07816640Acute Kidney Injury, Hepatectomy
Chinese PLA General Hospital
Not applicable
1,200
Hefei, Beijing, Chongqing, Lanzhou, Guangzhou, Nanning, Shijiazhuang, Harbin
2026-09-20
Not yet open
Treatment Strategy for Patients With RA-ILD
NCT07643038Rheumatoid Arthritis Associated Interstitial Lung Disease
Chinese SLE Treatment And Research Group
Phase 4
204
Luoyang, Beijing, Changchun, Chongqing, Dalian, Handan, Hangzhou, Hefei
2026-09-20
Not yet open
Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults
NCT07792681Migraine, With or Without Aura
Brise Pharmaceuticals Co., Ltd.
Phase 2/3
2,079
Shanxi, Inner Mongolia, Beijing, Anhui, Hebei, Jilin City, Hunan, Chongqing
2026-09-15
Recruiting
A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis
NCT07724366Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 3
400
Beijing, Chongqing, Guangzhou, Shenzhen, Nanning, Guiyang, Haikou, Chengde
2026-09-02
Not yet open
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
NCT07792954Obesity, Overweight
Pfizer
Phase 3
300
Hefei, Beijing, Chongqing, Huizhou, Hengshui, Shijiazhuang, Harbin, Luoyang
2026-09-01
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
NCT07796516Difficult-to-treat Rheumatoid Arthritis, Rheumatoid Arthritis
Peking University People's Hospital
Phase 2
420
Hefei, Beijing, Chongqing, Quanzhou, Guangzhou, Jiangmen, Shenzhen, Nanning
2026-09-01
Not yet open
Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response
NCT07797231Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
930
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Wuwei
2026-09
Not yet open
A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.
NCT07708441Uncontrolled or Resistant Hypertension
Shandong Suncadia Medicine Co., Ltd.
Phase 2/3
914
Chongqing, Shanghai
2026-09
Not yet open
Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)
NCT07712588Diffuse Large B-Cell Lymphoma (DLBCL)
Dizal Pharmaceuticals
Phase 2/3
880
Chongqing, Harbin, Changsha, Jinan, Shanghai
2026-09
Not yet open
A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors
NCT07818486Nasopharyngeal Carcinoma (NPC), Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
30
Chongqing, Guangzhou
2026-09
Recruiting
Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration
NCT07776522Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
West China Hospital
Phase 2
50
Beijing, Jilin City, Chongqing, Shantou, Zhejiang, Harbin, Zhengzhou, Wuhan
2026-08-31
Recruiting
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
NCT07797335Type 2 Diabetes, Cardiovascular Risk
Novo Nordisk A/S
Phase 3
1,778
Hefei, Beijing, Chongqing, Shenzhen, Cangzhou, Langfang, Shijiazhuang, Kaifeng
2026-08-24
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
NCT07753993Chronic Kidney Disease
AstraZeneca
Phase 3
7,000
Baoding, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chenzhou, Chongqing
2026-08-21
Not yet open
Betacyanin for Early Diagnosis and Recovery of Anastomotic Leakage After Rectal Cancer Surgery: A Single-Center, Prospective, Controlled Trial
NCT07726966Rectum Cancer, Anastomotic Leak
Southwest Hospital, China
Not applicable
120
Chongqing
2026-08-20
Recruiting
SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
NCT07700667Esophageal Squamous Cell Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
120
Changchun, Chengdu, Chongqing, Fuzhou, Haโ€™erbin, Jinan, Kunming, Luoyang
2026-08-13
Not yet open
Phase โ…ข Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
NCT07741045Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset
Hangzhou PhecdaMed Co., Ltd.
Phase 3
300
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2026-08-03
Recruiting
Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance
NCT07783971Fungal Diseases, Lung Cancer (NSCLC), Microbioata
958th Army Hospital of the Chinese People's Liberation Army
Observational
10
Chongqing
2026-08-01
Not yet open
Evaluation of NWRD09 for HPV-16 Related Cervical HSIL
NCT07712692High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd.
Phase 2
156
Beijing, Chongqing, Lanzhou, Baoding, Zhengzhou, Nanjing, Changchun, Jinan
2026-08-01
Not yet open
Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis
NCT07587671Liver Cirrhosis, Portal Hypertension, Gastroesophageal Varices Bleeding, Esophageal Varices
West China Hospital
Not applicable
240
Chengdu, Chongqing, Xiamen
2026-08-01
Not yet open
Efficacy and Safety of Accelerated Intermittent Theta-burst Stimulation (a-iTBS) in Adolescents With Depressive Disorder
NCT07369713Depression - Major Depressive Disorder
First Affiliated Hospital of Chongqing Medical University
Not applicable
45
Chongqing
2026-08-01
Not yet open
DEC003M in Prostate Cancer
NCT07657806Advanced Prostate Cancer
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
110
Chengdu, Hangzhou, Chongqing
2026-08-01
Not yet open
Phase III Study of OT202 in Treating Moderate to Severe Dry Eye
NCT07740564Dry Eye
Ocumension Therapeutics (Suzhou) Co., Ltd
Phase 3
842
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shantou
2026-08
Not yet open
A Study to Evaluate the Efficacy and Safety of ICP-488 in Participants With Primary Sjรถgren's Syndrome
NCT07727486Primary Sjรถgren's Syndrome
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
240
Beijing, Chongqing, Xiamen, Guangzhou, Nanning, Shijiazhuang, Changsha, Zhuzhou
2026-08
Not yet open
Diagnostic Accuracy and Safety of the Attention-Deficit/Hyperactivity Disorder Auxiliary Evaluation System (AHEF) in Chinese Children Aged 6 to 12
NCT07683156Attention-Deficit, Hyperactivity Disorder
Chongqing Jinsaixing Medical Technology Co., Ltd
Observational
570
Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Changchun, Shanghai, Chengdu
2026-07-31
Not yet open
Evaluating the Effectiveness of a Smart Screening and Tiered Management Tool for Diabetic Kidney Disease in Primary Care: A Cluster Randomized Trial
NCT07707518Type 2 Diabetes Mellitus, Diabetic Kidney Disease
First Affiliated Hospital of Chongqing Medical University
Not applicable
3,000
Chongqing
2026-07-30
Recruiting
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
NCT07492680Solid Tumors
Bristol-Myers Squibb
Phase 2
260
Beijing, Chongqing, Guangzhou, Xinxiang, Shanghai
2026-07-27
Recruiting
Single-port Robotic Radical Gastrectomy for Gastric Cancer
NCT07237126Gastric Cancer Patients Undergoing Gastrectomy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Not applicable
20
Chongqing
2026-07-22
Recruiting
Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria
NCT07512596Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
48
Bengbu, Beijing, Chongqing, Foshan, Guangzhou, Shenzhen, Zhuhai, Shijiazhuang
2026-07-21
Recruiting
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
NCT07406035Psoriatic Arthritis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
156
Bozhou, Beijing, Chongqing, Dongguan, Guangzhou, Jiangmen, Shenzhen, Nanning
2026-07-16
Recruiting
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
NCT07720284High-risk Muscle Invasive Urothelial Carcinoma
AstraZeneca
Phase 3
915
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou
2026-07-16
Recruiting
Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung Cancer
NCT07768124Lung Cancer (Diagnosis)Chemotherapy-Induced Nausea and Vomiting
Xiu Huang
Not applicable
60
Chongqing
2026-07-15
Recruiting
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT07622186Non-Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
150
Beijing, Chongqing, Fuzhou, Xiamen, Dongguan, Guangzhou, Guilin, Nanning
2026-07-15
Not yet open
Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma
NCT07700472Primary Aldosteronism, Aldosterone-Producing Adenoma
Chongqing Medical University
Not applicable
30
Chongqing
2026-07-15
Not yet open
A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease
NCT07677514Crohn's Disease
Jiangsu Carephar Pharmaceutical Co., Ltd.
Phase 2
156
Beijing, Bengbu, Changsha, Chongqing, Fujian, Guangzhou, Hefei, Huizhou
2026-07-12
Recruiting
A Study of MI078 for Postpartum Depression
NCT07721961Postpartum Depression (PPD)
Nanjing Minova Pharmaceutical Co., Ltd.
Phase 3
200
Hefei, Chongqing, Xiamen, Lanzhou, Guangzhou, Zhaoqing, Liuzhou, Guiyang
2026-07-10
Recruiting
DAREONยฎ-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
NCT07544654Extrapulmonary Neuroendocrine Cancer (epNEC)
Boehringer Ingelheim
Phase 3
390
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2026-07-10
Recruiting
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
NCT07600788Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Phase 1
32
Chongqing, Zhengzhou, Shanghai, Chengdu, Hangzhou
2026-07-09
Recruiting
Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism
NCT07673445Primary Aldosteronism
Chongqing Medical University
Not applicable
3,830
Chongqing
2026-07-07
Recruiting
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
NCT07614152Turner Syndrome
Xiamen Amoytop Biotech Co., Ltd.
Phase 3
84
Anyang, Beijing, Changsha, Chengdu, Chongqing, Dalian, Guangzhou, Hangzhou
2026-07-05
By invitation
Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec
NCT07658417Diabetes Mellitus, Type 2
Novo Nordisk A/S
Observational
216
Beijing, Chongqing, Lanzhou, Jiangmen, Langfang, Harbin, Shiyan, Huai'an
2026-07-02
Not yet open
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
NCT07575672HFpEF - Heart Failure With Preserved Ejection Fraction, TAVI(Transcatheter Aortic Valve Implantation), Finerenone
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
2,832
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Zhengzhou
2026-07-01
Not yet open
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
NCT07667517Albuminuria, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Diseases
First Affiliated Hospital of Zhejiang University
Phase 4
148
Chongqing, Fuzhou, Foshan, Guangzhou, Nantong, Suqian, Suzhou, Xi'an
2026-07-01
Not yet open
Deep Cervical Lymphovenous Anastomosis for Moderate Alzheimer's Disease
NCT07658430Alzheimer's Disease
Southwest Hospital, China
Not applicable
296
Chongqing
2026-07-01
Not yet open
Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke (SLEDAIS)
NCT07682922Acute Ischemic Stroke
Xinqiao Hospital of Chongqing
Phase 4
1,040
Chongqing
2026-07-01
Not yet open
IL-15 Enhanced NK Cell Therapy for Solid Tumors
NCT07621471Solid Tumors, Metastatic Cancer
Genovn Therapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1
12
Chongqing
2026-07-01
Not yet open
Weekend Warrior Exercise in Sedentary Female University Students
NCT07693504Sedentary Behavior
Chongqing Normal University
Not applicable
60
Chongqing
2026-07
Recruiting
Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
NCT07719140Childhood-onset Systemic Lupus Erythematosus, Lupus Nephritis (LN)
Peking Union Medical College Hospital
Phase 4
198
Beijing, Chongqing, Shenzhen, Changsha, Nanjing, Changchun, Shanghai
2026-07
Not yet open
Multicenter Prospective Validation of AI Models for Malignancy Risk Prediction in Pulmonary Nodules
NCT07727122Pulmonary Nodules
Guangdong Provincial People's Hospital
Observational
3,000
Chongqing, Guangzhou, Xuzhou, Hangzhou
2026-07
Recruiting
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China
NCT07604766Platinum-resistant Ovarian Cancer
Genmab
Phase 3
82
Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Jinan
2026-06-26
Recruiting
Study of AHB-171 in Chronic Hepatitis B Participants
NCT07630727Hepatitis B, Chronic (CHB)
Ausper Biopharma Co., Ltd.
Phase 2
138
Beijing, Chongqing, Xiamen, Guangzhou, Nanning, Zhengzhou, Changzhou, Jilin City
2026-06-24
Recruiting
A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus
NCT07509892Systemic Lupus Erythematosus
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
198
Bengbu, Bozhou, Beijing, Chongqing, Lanzhou, Guangzhou, Jiangmen, Shenzhen
2026-06-22
By invitation
Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy๏ผˆPRECAL๏ผ‰
NCT07721441Ulcerative Colitis (UC)
Tang-Du Hospital
Observational
200
Beijing, Chongqing, Shenzhen, Wuhan, Nanjing, Shengyang, Qingdao, Xiโ€™an
2026-06-18
Not yet open
Evaluation of the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of BBM-C101 Injection in Patients With Cervical High-Grade Squamous Intraepithelial Lesion(HSIL)
NCT07668960High-grade Squamous Intraepithelial Lesions of the Cervix Associated With Human Papillomavirus (HPV) Type 16 and/or HPV Type 18 Infection
Shanghai Mianyi Biopharmaceutical Co., Ltd.
Phase 1/2
60
Beijing, Chongqing, Zhangzhou, Jinan
2026-06-17
Recruiting
Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities
NCT07781124End Stage Renal Disease (ESRD), Chronic Kidney Disease (CKD)
Vantive Health LLC
Observational
750
Beijing, Chongqing, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Changsha
2026-06-17
Not yet open
Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial
NCT07699770Neuromyelitis Optica Spectrum Disorders (NMOSD), Neuropathic Pain
Tang-Du Hospital
Phase 4
110
Beijing, Chongqing, Harbin, Hohhot, Changchun, Shenyang, Xi'an, รœrรผmqi
2026-06-15
Active, closed
A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM
NCT07608354Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
AstraZeneca
Phase 2
326
Beijing, Changsha, Chongqing, Guangzhou, Hangzhou
2026-06-11
Recruiting
Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression
NCT07539805Major Depressive Disorder (MDD), Probiotic Intervention
First Affiliated Hospital of Chongqing Medical University
Phase 2
60
Longgang, Chongqing
2026-06-11
Recruiting
ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
NCT07517042Obesity, Weight Control
Shanghai Zhongshan Hospital
Not applicable
420
Chongqing, Fuzhou, Xiamen, Wuhan, Nanjing, Suzhou, Shanghai, Luzhou
2026-06-10
Recruiting
Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis
NCT07516184Suspected Asthma
AstraZeneca
Not applicable
500
Beijing, Cangzhou, Changsha, Chengdu, Chongqing, Guangzhou, Kunming, Quanzhou
2026-06-10
Recruiting
A Study to Evaluate AHB-137 Injection in Treatment-naรฏve Participants With Chronic Hepatitis B
NCT07635186Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Phase 2
320
Beijing, Chongqing, Xiamen, Guangzhou, Jiangmen, Meizhou, Qingyuan, Shenzhen
2026-06-05
Recruiting
Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas
NCT07744087Ampullary Carcinoma, Duodenal Adenocarcinoma, Distal Cholangiocarcinoma
Nanfang Hospital, Southern Medical University
Not applicable
232
Chongqing, Guangzhou, Chengdu, Jiancheng
2026-06-04
Active, closed
Effect of Ciprofol Injection on Postoperative Cognitive Function
NCT07673978Postoperative Cognitive Dysfunction
The Second Affiliated Hospital of Chongqing Medical University
Phase 4
298
Chongqing
2026-06-01
Active, closed
Effects of Microdosed Plyometric Training on Lower-Limb Neuromuscular Function and Sport-Specific Performance in Rope-Skipping Athletes
NCT07740096Athletic Performance Enhancement
Chongqing Normal University
Not applicable
60
Chongqing
2026-06-01
Not yet open
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
NCT07569757Multiple Myeloma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
260
Bengbu, Hefei, Beijing, Chongqing, Lanzhou, Guangzhou, Zhanjiang, Nanning
2026-06
Not yet open
Safety and Efficacy Evaluation of the Radiofrequency Therapeutic Device for the Treatment of Atrophic Acne Scars
NCT07620769Acne Scars, Acne Scars - Atrophic, Acne Scar, Acne Scarring
CLASSYS Inc.
Not applicable
252
Chengdu, Chongqing, Hebei, Shanghai
2026-06
Not yet open
Phase III Clinical Trial of Changji'an Capsules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver-Qi Invading Spleen Syndrome)
NCT07610434IBS, Diarrhea Predominant
Beijing Hospital of Traditional Chinese Medicine
Phase 3
636
Beijing, Chengdu, Chongqing, Guangzhou, Guizhou, Haozhou, Hebei, Heilongjiang
2026-05-31
Not yet open
JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
NCT07582822Advanced Solid Tumor
Biotech Pharmaceutical Co., Ltd.
Phase 1
60
Chongqing, Zhengzhou, Changsha, Nanjing, Xi'an, Shanghai, Taiyuan, Chengdu
2026-05-30
Recruiting
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPROยฎ in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
NCT07477587Multiple Myeloma (MM)
Shanghai Henlius Biotech
Phase 1
258
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Meizhou
2026-05-27
Recruiting
Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.
NCT07279935Non-small Cell Lung Cancer
AstraZeneca
Phase 4
100
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan
2026-05-26
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856Colitis, Ulcerative
Janssen Research & Development, LLC
Phase 3
644
Beijing, Changzhou, Chongqing, Guangzhou, Huai'an, Ningbo, Shijiazhuang, Zhuzhou
2026-05-23
Recruiting
A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors
NCT07541534Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase 1
41
Chongqing, Jinan, Shanghai, Wuhan
2026-05-22
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
NCT07577843Crohn Disease
Janssen Research & Development, LLC
Phase 3
460
Beijing, Changzhou, Chongqing, Guangzhou, Hangzhou, Huai'an, Ningbo, Zhuzhou
2026-05-22
Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
NCT07492641HR+/HER2- Breast Cancer
BeOne Medicines
Phase 3
1,056
Bengbu, Beijing, Chongqing, Fuzhou, Guangzhou, Shantou, Nanning, Haikou
2026-05-22
Recruiting
Safety and Preliminary Activity of BI115 in Advanced SCLC
NCT07559019Small Cell Lung Cancer (SCLC)
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
150
Chongqing
2026-05-21
Recruiting
Shortwave Intervention for Diabetic Peripheral Neuropathy.
NCT07625007Diabetic Peripheral Neuropathy
Chongqing Medical University
Not applicable
202
Chongqing
2026-05-20
Recruiting
Ultrasound-Guided Nerve Hydrodissection for Diabetic Lower Limb Entrapment Neuropathy
NCT07625020Diabetic Peripheral Neuropathy, Entrapment Neuropathy
Chongqing Medical University
Not applicable
266
Chongqing
2026-05-20
Recruiting
A Study of SKB571 in Participants With Gastrointestinal Tumors
NCT07564466Gastrointestinal Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
120
Chongqing, Fuzhou, Xiamen, Guangzhou, Nanning, Shijiazhuang, Harbin, Luoyang
2026-05-20
Recruiting
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
NCT07607275Hypertension, Essential (Primary) Hypertension
Beijing Anzhen Hospital
Phase 4
350
Beijing, Chongqing, Dalian, Hohhot, Longyan, Luohe, Nanchang, Nanjing
2026-05-15
Recruiting
Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection
NCT07519330Chronic Hepatitis B Virus Infection
Huahui Health
Phase 2
45
Chongqing
2026-05-14
Recruiting
A Phase โ…ก/โ…ข Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer
NCT07462143Colorectal (Colon or Rectal) Cancer
RemeGen Co., Ltd.
Phase 2/3
80
Beijing, Chongqing, Fuzhou, Meizhou, Nanjing, Shijiazhuang, Zhengzhou, Wuhan
2026-05-12
Recruiting
Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
NCT07379047GIST - Gastrointestinal Stromal Tumor, Advanced
Ningbo Newbay Technology Development Co., Ltd
Phase 2/3
255
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Guiyang, Shijiazhuang
2026-05-11
Recruiting
Clinical Trials of IBI3035 in Healthy Subjects
NCT07591519Healthy Person
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
144
Chongqing
2026-05-08
Recruiting
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07611110Metastatic Castration-resistant Prostate Cancer
AstraZeneca
Phase 3
670
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanjing
2026-05-04
Not yet open
A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer
NCT07543848Rectal Neoplasms, Rectal Adenocarcinoma
Chongqing University Cancer Hospital
Phase 2
20
Chongqing
2026-05-01
Not yet open
Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT
NCT07550894Acute Kidney Injury, Sepsis, Critically Ill Patients Requiring Continuous Renal Replacement Therapy
Sun Yat-sen University
Phase 3
220
Chongqing, Guangzhou, Nanning, Luoyang, Zhengzhou, Wuhan, Nanjing, Xi'an
2026-05-01
Not yet open
LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer
NCT07453875Peritoneal Metastasis of Gastric and Colorectal Cancer, LDRT
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 1
9
Chongqing
2026-05
Rows per page Showing 1–100 of 1056
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/chongqing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,056 of those studies with a site in Chongqing.

How many clinical trials are recruiting in Chongqing?

589 of the 1,056 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 118 have not yet opened recruitment, 334 are active but closed to new participants, and 15 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chongqing), 1,056 studies
PhaseStudiesRecruitingShare
Phase 341319139.1%
Phase 21559614.7%
Observational1407613.3%
Not applicable1287712.1%
Phase 1/273526.9%
Phase 163476%
Phase 444224.2%
Phase 2/332213%
Phase EARLY_PHASE1870.8%

Most active sponsors

Lead sponsors with the most studies (Chongqing)
Lead sponsorStudiesRecruiting
AstraZeneca9946
Merck Sharp & Dohme LLC3919
Janssen Research & Development, LLC3814
First Affiliated Hospital of Chongqing Medical University3722
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University3015
Eli Lilly and Company2917
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2713
Bristol-Myers Squibb1911
Chongqing University Cancer Hospital1812
The Second Affiliated Hospital of Chongqing Medical University1811
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.